What Is Psilocybin? Other Names: Psilocibin, Psilocybine, Psilocin Phosphate Ester

Have a question about science, health, fitness, or diet? Get cited, evidence-based insights: Consensus is an AI-Powered Academic Search Engine.

Try for free
Contents
    Written by Consensus AI
    7 min read

    What is Psilocybin?

    This post was written with Consensus AI Academic Search Engine – please read our Disclaimer at the end of this article. Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms, commonly referred to as “magic mushrooms.” This compound has been used for centuries in various cultural and spiritual rituals. In recent years, psilocybin has garnered significant attention in the scientific community for its potential therapeutic benefits, particularly in the treatment of various neuropsychiatric conditions. Other names include: 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl] Dihydrogen Phosphate, 4-Phosphoryloxy-N,N-Dimethyltryptamine, O-Phosphoryl-4-Hydroxy-N,N-Dimethyltryptamine, Psilocibin, Psilocybine, Psilocin Phosphate Ester.

    Historical Context

    Historically, psilocybin has been used in religious and spiritual ceremonies by indigenous cultures. Its use was largely popularized in the Western world during the 1960s counterculture movement, which led to its stigmatization and subsequent classification as a Schedule 1 drug by the U.S. government in 1970. This classification significantly hindered scientific research into its potential benefits1.

    Therapeutic Potential of Psilocybin

    Depression and Anxiety

    Several studies have demonstrated the efficacy of psilocybin in treating depression and anxiety, particularly in patients with life-threatening illnesses. For instance, a randomized double-blind trial found that high doses of psilocybin significantly reduced symptoms of depression and anxiety in cancer patients, with effects lasting up to six months2 4 6. Another study highlighted its potential in treatment-resistant depression, showing marked and sustained improvements in depressive symptoms10.

    Cognitive and Emotional Functions

    Research has also explored the effects of psilocybin on cognitive and emotional functions. A phase 1 trial involving healthy participants found that psilocybin did not have detrimental effects on cognitive functioning or emotional processing, suggesting its safety in controlled settings5. Additionally, psilocybin has been shown to enhance autobiographical recollection, which could be useful in psychotherapy9.

    Prosocial Attitudes and Behaviors

    Psilocybin has been found to produce enduring positive changes in psychological functioning and prosocial attitudes. A study involving participants who undertook a program of meditation and spiritual practices alongside psilocybin administration reported significant improvements in interpersonal closeness, gratitude, and life meaning3.

    Safety and Tolerability

    Psilocybin is generally well-tolerated when administered in controlled settings. Common adverse effects include transient anxiety, confusion, and nausea, but these are typically short-lived and manageable5 10. No serious adverse events have been reported in recent clinical trials, further supporting its safety profile.

    Learn more with Consensus:

     


    Psilocybin Chemical Properties and Mechanism of Action

    Psilocybin is a tryptamine compound that acts as a partial agonist at serotonin receptors, particularly the 5-HT2A receptor. This interaction is believed to be responsible for its psychedelic effects, which include altered perception, mood, and cognition5 6. Recent studies have shown that psilocybin can alter functional connectivity patterns in the brain, which may underlie its therapeutic effects8.

    Learn more with Consensus:

     


    Adverse Effects of Psilocybin

    Common Acute Adverse Effects

    Psilocybin can cause transient anxiety, dysphoria, panic, nausea, headache, dizziness, and gastrointestinal issues such as nausea, diarrhea, and vomiting .

    Cardiovascular effects like tachycardia and increased blood pressure have been observed .

    Management of Acute Adverse Effects

    Acute adverse reactions, such as strong dysphoria and anxiety, were managed successfully with interpersonal support without the need for pharmacological intervention .

    Long-term and Serious Adverse Effects

    No long-term impairments such as persistent perception disorders, prolonged psychosis, or drug abuse were reported in controlled settings .

    Serious adverse events, including suicidal ideation or behavior, were noted but were not directly attributed to psilocybin in controlled environments .

    Psychiatric and Cognitive Effects

    Transient confusion or thought disorder and mild cognitive impairments were reported during the acute phase post-intake but generally resolved quickly .

    No significant long-term cognitive or emotional processing impairments were observed .

    Safety in Controlled Environments

    Psilocybin was generally well-tolerated in controlled, supportive environments, with no serious adverse effects reported .

    Learn more with Consensus:

     


    How has Psilocybin Improved Patient Outcomes?

    Reduction in Anxiety and Depression in Cancer Patients

    Psilocybin has been shown to produce rapid, substantial, and sustained improvements in anxiety and depression in cancer patients, with effects lasting up to 6.5 months . These improvements are often accompanied by enhanced quality of life, spiritual well-being, and reduced death anxiety .

    Long-term Efficacy in Major Depressive Disorder (MDD)

    Psilocybin-assisted therapy has demonstrated significant and lasting antidepressant effects in patients with MDD, with benefits persisting for up to 12 months post-treatment. Participants reported large decreases in depression scores and high rates of treatment response and remission.

    Treatment-Resistant Depression (TRD)

    In patients with TRD, psilocybin has been associated with marked reductions in depressive symptoms, with effects observed as early as one week post-treatment and lasting up to six months . The quality of the acute psychedelic experience, particularly mystical-type experiences, has been linked to better therapeutic outcomes .

    Improvement in Substance Use Disorders (SUDs)

    Psilocybin-assisted therapy has shown promise in reducing alcohol and tobacco use. Studies have reported significant decreases in heavy drinking days and high rates of smoking abstinence following treatment. Ongoing trials aim to further establish its efficacy in treating alcohol use disorder.

    Learn more with Consensus:

     


    Common Complaints Associated with Psilocybin Use

    Gastrointestinal Issues and Headaches

    Common adverse reactions include headaches, nausea, diarrhea, and vomiting .

    Cardiovascular Effects

    Psilocybin can cause tachycardia (increased heart rate) and arterial hypertension (high blood pressure).

    Transient Psychological Effects

    Users may experience transient anxiety, confusion, or thought disorder during the onset of the drug’s effects .

    Acute adverse reactions such as strong dysphoria and panic were noted, particularly at higher doses, but these were manageable with interpersonal support.

    Hallucinogenic Persisting Perception Disorder (HPPD)

    Although HPPD is a concern, it was not observed in controlled study conditions and is more likely associated with recreational use.

    Risk of “Bad Trips” and Delusional Experiences

    There is a risk of experiencing “bad trips” or delusional episodes, which can lead to risky behaviors, especially in uncontrolled environments.

    Manic Symptoms and Sleep Difficulties in Bipolar Disorder

    In individuals with bipolar disorder, psilocybin use can lead to new or increased symptoms, including manic episodes and sleep disturbances.

    Learn more with Consensus:

     


    Disclaimer

    The content presented in this blog is generated by Consensus, an AI-powered academic search engine, and is based on publicly available scientific literature. While every effort is made to provide accurate, up-to-date, and well-researched information, the content is intended for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any decisions regarding medical conditions, treatments, or medications. The AI system’s analysis may not cover all perspectives, emerging research, or individual cases, and it is not a substitute for professional expertise. Neither the blog publisher nor the developers of the AI-powered search engine are responsible for any actions taken based on the information provided in this content. Use of this information is at your own risk. Citations to the original scientific studies are included for reference, but these studies should be reviewed in full and interpreted with the guidance of a healthcare or research professional.

    If you are experiencing a medical emergency, please seek immediate attention from a healthcare provider.

    Have a question about science, health, fitness, or diet? Get cited, evidence-based insights: Consensus is an AI-Powered Academic Search Engine.

    Try for free
    Contents